Indian pharmaceutical giant Wockhardt is currently in merger talks. The company, known for its extensive portfolio of generic and branded medications, has been facing headwinds in recent quarters. Sources close to the deal suggest that Wockhardt is {attracting interest from|being courted by both domestic and international firms. A final decision is